Long-term treatment with responsive brain stimulation in adults with refractory partial seizures

Neurology

Volumn 84, Issue 8, 2015, Pages 810-817

  Bergey, Gregory K ^a   Morrell, Martha J ^b,ah   Mizrahi, Eli M ^c   Goldman, Alica ^c   King Stephens, David ^d   Nair, Dileep ^e   Srinivasan, Shraddha ^f   Jobst, Barbara ^g   Gross, Robert E ^h   Shields, Donald C ⁱ   Barkley, Gregory ^j   Salanova, Vicenta ^k   Olejniczak, Piotr ^l   Cole, Andrew ^m   Cash, Sydney S ^m   Noe, Katherine ⁿ   Wharen, Robert ⁿ   Worrell, Gregory ^o   Murro, Anthony M ^p   Edwards, Jonathan ^q   Duchowny, Michael ^r   Spencer, David ^s   Smith, Michael ^t   Geller, Eric ^u   Gwinn, Ryder ^v   Skidmore, Christopher ^w   Eisenschenk, Stephan ^x   Berg, Michel ^y   Heck, Christianne ^z   Van Ness, Paul ^aa   Fountain, Nathan ^ab   Rutecki, Paul ^ac   Massey, Andrew ^ad   O'Donovan, Cormac ^ae   Labar, Douglas ^af   Duckrow, Robert B ^ag   Hirsch, Lawrence J ^ag   Courtney, Tracy ^ah   Sun, Felice T ^ah   Seale, Cairn G ^ah   more..

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b STANFORD UNIVERSITY   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f NewYork Presbyterian Hospital   (United States)

^g DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^h EMORY UNIVERSITY   (United States)

ⁱ GEORGE WASHINGTON UNIVERSITY   (United States)

^j HENRY FORD HOSPITAL   (United States)

^k INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^m MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁿ MAYO CLINIC   (United States)

^o MAYO CLINIC ROCHESTER   (United States)

^p AUGUSTA UNIVERSITY   (United States)

^q MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^r MIAMI CHILDREN'S HOSPITAL   (United States)

^s OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^t RUSH UNIVERSITY MEDICAL CENTER   (United States)

^u Institute of Neurology and Neurosurgery at St Barnabas   (United States)

^v SWEDISH MEDICAL CENTER   (United States)

^w THOMAS JEFFERSON UNIVERSITY   (United States)

^x UNIVERSITY OF FLORIDA   (United States)

^y UNIVERSITY OF ROCHESTER   (United States)

^z UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^aa UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^ab UNIVERSITY OF VIRGINIA   (United States)

^ac UNIVERSITY OF WISCONSIN MADISON   (United States)

^ad Via Christi Hospital   (United States)

^ae WAKE FOREST UNIVERSITY   (United States)

^af WEILL CORNELL MEDICAL COLLEGE   (United States)

^ag YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ah Neuropace   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DEVICE INFECTION; ELECTROCORTICOGRAPHY; EROSION; EXPLANT; FEMALE; FOCAL EPILEPSY; FOLLOW UP; HUMAN; IMPLANTABLE NEUROSTIMULATOR; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOFT TISSUE; SOFT TISSUE INFECTION; THERAPY EFFECT; TONIC CLONIC SEIZURE; TREATMENT RESPONSE; ADOLESCENT; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; EPILEPSIES, PARTIAL; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TIME FACTOR; TREATMENT OUTCOME; TRENDS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; DEEP BRAIN STIMULATION; DOUBLE-BLIND METHOD; EPILEPSIES, PARTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84923668277     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001280     Document Type: Article

References (41)

1. Morrell MJ; RNS System in Epilepsy Study Group. Responsive cortical stimulation for the treatment of medically intractable partial epilepsy. Neurology 2011; 77:1295-1304
2. The Vagus Nerve Stimulation Study Group. A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. Neurology 1995;45:224-230
3. Handforth A, DeGiorgio CM, Schachter SC, et al. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology 1998;51:48-55
4. Morris GL III, Mueller WM. Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy: The Vagus Nerve Stimulation Study Group E01-E05. Neurology 1999;53:1731-1735
5. Morris GL III, Gloss D, Buchhalter J, Mack KJ, Nickels K, Harden C. Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2013;81:1453-1459
6. Fisher R, Salanova V, Witt T, et al. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia 2010;51:899-908
7. RNS System, Summary of Safety and Effectiveness, P100026. U S Department of Health and Human Services, Food and Drug Administration. Available at: www. accessdata.fda.gov/cdrh-docs/pdf10/p100026b.pdf. Accessed August 14, 2014
8. Heck CN, King-Stephens D, Massey AD, et al. Two-year seizure reduction in adults with medically intractable partial onset epilepsy treated with responsive neurostimulation: final results of the RNS System Pivotal trial. Epilepsia 2014;55:432-441
9. Sun FT, Morrell MJ. Closed-loop neurostimulation: the clinical experience. Neurotherapeutics 2014;11:553-563
10. Devinsky O, Vickrey BG, Cramer J, et al. Development of the quality of life in epilepsy inventory. Epilepsia 1995;36: 1089-1104
11. Lozano AM, Lipsman N. Probing and regulating dysfunctional circuits using deep brain stimulation. Neuron 2013; 77:406-424
12. DeGiorgio CM, Schachter SC, Handforth A, et al. Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia 2000;41:1195-1200
13. Greenberg BD, Malone DA, Friehs GM, et al. Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology 2006;31:2384-2393
14. Isaias IU, Alterman RL, Tagliati M. Deep brain stimulation for primary generalized dystonia: long-term outcomes. Arch Neurol 2009;66:465-470
15. Hess CW, Vaillancourt DE, Okun MS. The temporal pattern of stimulation may be important to the mechanism of deep brain stimulation. Exp Neurol 2013;247:296-302
16. Feng Z, Zheng X, Yu Y, Durand DM. Functional disconnection of axonal fibers generated by high frequency stimulation in the hippocampal CA1 region in-vivo. Brain Res 2013;1509:32-42
17. Jensen AL, Durand DM. High frequency stimulation can block axonal conduction. Exp Neurol 2009;220:57-70
18. Hashimoto T, Elder CM, Okun MS, Patrick SK, Vitek JL. Stimulation of the subthalamic nucleus changes the firing pattern of pallidal neurons. J Neurosci 2003;23: 1916-1923
19. Stone SS, Teixeira CM, Devito LM, et al. Stimulation of entorhinal cortex promotes adult neurogenesis and facilitates spatial memory. J Neurosci 2011;31:13469-13484
20. Stavrinou LC, Boviatsis EJ, Stathis P, Leonardos A, Panourias IG, Sakas DE. Sustained relief after discontinuation of DBS for dystonia: implications for the possible role of synaptic plasticity and cortical reorganization. J Neurol Surg A Cent Eur Neurosurg 2012;73:175-178
21. Behrens E, Schramm J, Zentner J, Konig R. Surgical and neurological complications in a series of 708 epilepsy surgery procedures. Neurosurgery 1997;41:1-9
22. Wong CH, Birkett J, Byth K, et al. Risk factors for complications during intracranial electrode recording in presurgical evaluation of drug resistant partial epilepsy. Acta Neurochir 2009;151:37-50
23. Silberbusch MA, Rothman MI, Bergey GK, Zoarski GH, Zagardo MT. Subdural grid implantation for intracranial EEG recording: CT and MR appearance. AJNR Am J Neuroradiol 1998;19:1089-1093
24. Engel J Jr, Wiebe S, French J, et al. Practice parameter: temporal lobe and localized neocortical resections for epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology, in association with the American Epilepsy Society and the American Association of Neurological Surgeons. Neurology 2003; 60:538-547
25. Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 2001;345:311-318
26. Weaver FM, Follett K, Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009;301:63-73
27. Marson AG, Al-Kharusi A, Alwaidh M, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007;369:1000-1015
28. French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004; 62:1261-1273
29. Krauss GL, Perucca E, Ben-Menachem E, et al. Perampanel, a selective, noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from phase III, extension study 307. Epilepsia 2013;54:126-134
30. Ben-Menachem E, Biton V, Jatuzis D, bou-Khalil B, Doty P, Rudd GD. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia 2007;48:1308-1317
31. Shorvon S, Tomson T. Sudden unexpected death in epilepsy. Lancet 2011;378:2028-2038
32. Dasheiff RM. Sudden unexpected death in epilepsy: a series from an epilepsy surgery program and speculation on the relationship to sudden cardiac death. J Clin Neurophysiol 1991;8:216-222
33. Institute of Medicine. Epilepsy Across the Spectrum: Promoting Health and Understanding.Washington, DC: The National Academies Press; 2012
34. Perucca P, Carter J, Vahle V, Gilliam FG. Adverse antiepileptic drug effects: toward a clinically and neurobiologically relevant taxonomy. Neurology 2009;72:1223-1229
35. Zaccara G, Franciotta D, Perucca E. Idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia 2007; 48:1223-1244
36. Hermann BP, Seidenberg M, Dow C, et al. Cognitive prognosis in chronic temporal lobe epilepsy. Ann Neurol 2006;60:80-87
37. Leidy NK, Elixhauser A, Vickrey B, Means E, Willian MK. Seizure frequency and the health-related quality of life of adults with epilepsy. Neurology 1999; 53:162-166
38. Loring DW, Meador KJ, Lee GP. Determinants of quality of life in epilepsy. Epilepsy Behav 2004;5:976-980
39. Bootsma HP, Ricker L, Hekster YA, et al. The impact of side effects on long-term retention in three new antiepileptic drugs. Seizure 2009;18:327-331
40. Zaccara G, Messori A, Cincotta M, Burchini G. Comparison of the efficacy and tolerability of new antiepileptic drugs: what can we learn from long-term studies? Acta Neurol Scand 2006;114:157-168
41. Chung S, Wang N, Hank N. Comparative retention rates and long-term tolerability of new antiepileptic drugs. Seizure 2007;16:296-304.